Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2015

View Archived Issues

Novel small-molecule inhibitors confirm the involvement of PADI4 in neutrophil trap formation

FRAXA grant to Neurotrope preclinical behavioral studies of bryostatin for fragile X syndrome

AGTC and 4DMT collaborate in AAV-gene therapies for ophthalmic diseases

Curadev partners with Roche on IDO-1 and TDO inhibitors

FDA grants priority review to Adcetris supplemental BLA

FDA assigns obinutuzumab orphan drug status for follicular lymphoma

U.S. orphan drug status conferred on triheptanoin for fatty acid oxidation disorders

Preclinical evaluation of the selective FGFR inhibitor INCB-054828

FP-208, an mTOR inhibitor, shows potential for cancer in preclinical studies

An orally available MKNK1 inhibitor from Bayer

TetraLogic and Merck & Co. to collaborate on phase I trial of birinapant and pembrolizumab

Novel zefrafish model for detecting apoptosis

Euroscreen starts phase II trials of ESN-364 in uterine fibroids and polycystic ovary syndrome

SHAL Technologies receives NCI grant to fund preclinical testing of SH-7139

Uric acid as a novel predictive biomarker in ankylosing spondylitis

Pain Therapeutics regains rights to Remoxy from Pfizer

Nimbus Discovery patents IRAK-4 inhibitors

Pfizer's crizotinib receives FDA breakthrough therapy designation for ROS1-positive NSCLC

Pharmakea discloses autotaxin inhibitors

Astex Therapeutics develops prodrugs of gemcitabine and cytarabine

Olatec Industries patents compound for pain and inflammation

Sanford-Burnham Medical Research Institute patent describes EBI2 modulators

Relmada initiates proof-of-concept study for oral buprenorphine

scPharmaceuticals initiates pivotal trial of furosemide solution for subcutaneous administration

Inovio initiates phase I trial of HBV DNA vaccine INO-1800

Teva makes play for Mylan as Perrigo rejects Mylan proposal

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...